Hepatocellular cancer therapy in patients with HIV infection: Disparities in cancer care, trials enrolment, and cancer-related research

In the highly active antiretroviral therapy (HAART) era, hepatocellular carcinoma (HCC) is arising as a common late complication of human immunodeficiency virus (HIV) infection, with a great impact on morbidity and mortality. Though HIV infection alone may not be sufficient to promote hepatocarcinog...

Descripción completa

Detalles Bibliográficos
Autores principales: Negri, Francesca, Missale, Gabriele, Antoni, Anna Degli, Porta, Camillo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220238/
https://www.ncbi.nlm.nih.gov/pubmed/34144349
http://dx.doi.org/10.1016/j.tranon.2021.101153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220238/
https://www.ncbi.nlm.nih.gov/pubmed/34144349
http://dx.doi.org/10.1016/j.tranon.2021.101153

Ejemplares similares